RxDoctor Payments Data

Natalie Birt-Coy

Psychiatric/Mental Health · Dublin, OHNPI 1972192243

Payments from drug & device makers

$279in general payments, 2019–2025

Across 15 payments — averaging $18.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$52
  • Supernus Pharmaceuticals, Inc.$38
  • Teva Pharmaceuticals USA, Inc.$34
  • Alkermes, Inc.$32
  • Johnson & Johnson$30
  • Otsuka America Pharmaceutical, Inc.$23
  • plus $71 from 4 others

What the payments were for

  • Food & beverage$279100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$279 in reported general payments places this provider in the 30th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio

Medicare billing

Part B allowed, 2024
$64,409
Medicare patients
205
Services billed
738

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate18$139,000
Invega SustennaPaliperidone Palmitate30$95,693
RexultiBrexpiprazole42$63,175
VraylarCariprazine Hcl30$41,949
AristadaAripiprazole Lauroxil13$38,800
FanaptIloperidone35$32,856
Aripiprazole304$28,063
Paliperidone ErPaliperidone84$17,993
NuedextaDextromethorphan Hbr/Quinidine12$16,646
TrintellixVortioxetine Hydrobromide33$12,457
Divalproex Sodium ErDivalproex Sodium134$8,678
Oxcarbazepine133$7,683
Lurasidone Hcl24$6,384
Divalproex Sodium148$4,318
Fluvoxamine Maleate88$3,781

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$22$139,00018 claims
Johnson & JohnsonInvega Sustenna$30$95,69330 claims
Otsuka America Pharmaceutical, Inc.Rexulti$23$63,17542 claims
AbbVieVraylar$52$41,94930 claims
Alkermes, Inc.Aristada$32$38,80013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 1,808 psychiatric/mental health providers in Ohio.

Other psychiatric/mental health in Dublin

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →